Will Investors Benefit From Johnson & Johnson's Breakup?
In one of the biggest surprises of the year, Johnson & Johnson (NYSE: JNJ) has announced that it will break off its consumer health division from its pharmaceutical and medical device units. In this Motley Fool Live video recorded on Nov. 15, Motley Fool contributors Keith Speights and Brian Orelli discuss the rationale behind the decision, which is largely driven by the slow growth of the consumer health unit in comparison to the other two. Investors seeking income may have to deal with holding shares of both J&J and the spinoff, but others hoping for faster growth in Johnson & Johnson should welcome the change.
Source Fool.com
